WS12-4 Long-term safety and efficacy of...

WS12-4 Long-term safety and efficacy of lumacaftor/ivacaftor therapy in patients aged 6–11 years with cystic fibrosis homozygous for the F508del-CFTR mutation (F/F)

Chilvers, M., Davies, J.C., Ratjen, F., Milla, C., Owen, C.A., Tian, S., Han, Z., Wang, L.T.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(19)30189-4
Date:
June, 2019
File:
PDF, 60 KB
english, 2019
Conversion to is in progress
Conversion to is failed